OBJECTIVES/HYPOTHESIS: To evaluate the ability of the Ad28.gfap.atoh1 to promote hair cell regeneration and hearing recovery in cochlea injured with kanamycin and furosemide. STUDY DESIGN: In vivo model of hair cell ablation and subsequent treatment with Atoh1. METHODS: The hair cells of C57BL/6 mice were ablated with systemic administration of kanamycin and furosemide. The left ears were treated with Ad28.gfap.atoh1. The right ears were not treated. Preablation audiograms and distortion product otoacoustic emissions (DPOAEs) were compared to 1- or 2-month postablation studies. Harvested cochleae were examined for histologic evidence of hair cell regeneration and spiral ganglion cell survival. RESULTS: Delivery of Ad28.gfap.atoh1 results in development of auditory hair cells. There was no recovery of DPOAEs at 1 or 2 months post-treatment. Two months after delivery of Ad28.gfap.atoh1, the left ear exhibited a moderate recovery of hearing at 4 and 8 kHz (P < .01). There was no significant difference at 16 or 32 kHz. One month after treatment, myosin VII-positive immunohistochemical staining can be seen in both the inner and outer hair cells of the treated ear. In the untreated ear, minimal myosin VII-positive debris is seen, with no indication of normal hair cells. Two months after ablation, there is evidence of hair cell recovery on the treated side, whereas the untreated cochlea demonstrates a flattened epithelium. Untreated ears showed decreased spiral ganglion cell density at the basal turn compared to treated ears. CONCLUSIONS: Ad28.gfap.atoh1 promotes hair cell regeneration in cochlea ablated with kanamycin and furosemide resulting in moderate hearing recovery.
OBJECTIVES/HYPOTHESIS: To evaluate the ability of the Ad28.gfap.atoh1 to promote hair cell regeneration and hearing recovery in cochlea injured with kanamycin and furosemide. STUDY DESIGN: In vivo model of hair cell ablation and subsequent treatment with Atoh1. METHODS: The hair cells of C57BL/6 mice were ablated with systemic administration of kanamycin and furosemide. The left ears were treated with Ad28.gfap.atoh1. The right ears were not treated. Preablation audiograms and distortion product otoacoustic emissions (DPOAEs) were compared to 1- or 2-month postablation studies. Harvested cochleae were examined for histologic evidence of hair cell regeneration and spiral ganglion cell survival. RESULTS: Delivery of Ad28.gfap.atoh1 results in development of auditory hair cells. There was no recovery of DPOAEs at 1 or 2 months post-treatment. Two months after delivery of Ad28.gfap.atoh1, the left ear exhibited a moderate recovery of hearing at 4 and 8 kHz (P < .01). There was no significant difference at 16 or 32 kHz. One month after treatment, myosin VII-positive immunohistochemical staining can be seen in both the inner and outer hair cells of the treated ear. In the untreated ear, minimal myosin VII-positive debris is seen, with no indication of normal hair cells. Two months after ablation, there is evidence of hair cell recovery on the treated side, whereas the untreated cochlea demonstrates a flattened epithelium. Untreated ears showed decreased spiral ganglion cell density at the basal turn compared to treated ears. CONCLUSIONS: Ad28.gfap.atoh1 promotes hair cell regeneration in cochlea ablated with kanamycin and furosemide resulting in moderate hearing recovery.
Authors: Ronald Vogels; David Zuijdgeest; Richard van Rijnsoever; Eric Hartkoorn; Irma Damen; Marie-Pierre de Béthune; Stefan Kostense; Germaine Penders; Niels Helmus; Wouter Koudstaal; Marco Cecchini; Antoinette Wetterwald; Mieke Sprangers; Angelique Lemckert; Olga Ophorst; Björn Koel; Michelle van Meerendonk; Paul Quax; Laura Panitti; Jos Grimbergen; Abraham Bout; Jaap Goudsmit; Menzo Havenga Journal: J Virol Date: 2003-08 Impact factor: 5.103
Authors: K Abrahamsen; H L Kong; A Mastrangeli; D Brough; A Lizonova; R G Crystal; E Falck-Pedersen Journal: J Virol Date: 1997-11 Impact factor: 5.103
Authors: Mark Praetorius; Chi Hsu; Kim Baker; Douglas E Brough; Peter Plinkert; Hinrich Staecker Journal: Acta Otolaryngol Date: 2010-02 Impact factor: 1.494
Authors: Xiaoping Du; Qunfeng Cai; Matthew B West; Ibrahima Youm; Xiangping Huang; Wei Li; Weihua Cheng; Don Nakmali; Donald L Ewert; Richard D Kopke Journal: Mol Ther Date: 2018-03-10 Impact factor: 11.454
Authors: Chenkai Dai; Mohamed Lehar; Daniel Q Sun; Lani Swarthout Rvt; John P Carey; Tim MacLachlan; Doug Brough; Hinrich Staecker; Alexandra M Della Santina; Timothy E Hullar; Charles C Della Santina Journal: J Assoc Res Otolaryngol Date: 2017-06-23
Authors: Adam J Mellott; Keerthana Devarajan; Heather E Shinogle; David S Moore; Zsolt Talata; Jennifer S Laurence; M Laird Forrest; Sumihare Noji; Eiji Tanaka; Hinrich Staecker; Michael S Detamore Journal: Tissue Eng Part A Date: 2015-04-13 Impact factor: 3.845